Archives: “Early Disease Detection”

An Integrative Multi-modal Approach to Define and Diagnose Pediatric Autoimmune Neurological Disorders

Building the largest cerebrospinal fluid immune profile dataset in pediatric autoimmune neurological diseases to enable faster, more accurate diagnosis of MS and related conditions.

Molecular Determinants of Systemic Immune Reactivation in Patients with ANCA-Associated Vasculitis

Profiling deep immune changes before AAV relapse to identify predictive biomarkers and therapeutic targets for this difficult-to-manage autoimmune vasculitis.

Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab

Understanding the spectrum from preclinical psoriatic arthritis to early diagnosis of the disease

Vessel wall MRI in giant cell arteritis: standardized protocol and scoring approach developed by an international working group

Soluble urine activated leukocyte cell adhesion molecule is a strong predictor of lupus nephritis

Teplizumab induces persistent changes in the antigen-specific repertoire in individuals at risk for type 1 diabetes

Multimorbidity in psoriasis as a risk factor for psoriatic arthritis: a population-based study

Opportunities for improving biopsy and non-biopsy-based diagnosis of celiac disease

Pediatric cerebrospinal fluid immune profiling distinguishes pediatric-onset multiple sclerosis from other pediatric-onset acute neurological disorders